Research Square
Combined Use of Glp-1 Receptor Agonists and Sglt2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Observational Cohort Studies
Preprint: study in peopleInterventions
- GLP-1 receptor agonists + SGLT2 inhibitors
- GLP-1 and incretin signalling
- Type 2 diabetes
- Heart failure
- Myocardial infarction
- Humans
The paper
Kahramanmaraş Sütçü İmam University
Research Square, 10 Sep 2026, Preprint, not peer-reviewed
